292 related articles for article (PubMed ID: 15669896)
1. Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders.
Bergman J; Dwolatzky T; Brettholz I; Lerner V
J Clin Psychiatry; 2005 Jan; 66(1):107-10. PubMed ID: 15669896
[TBL] [Abstract][Full Text] [Related]
2. Treatment of tardive dyskinesia with donepezil: a pilot study.
Caroff SN; Campbell EC; Havey J; Sullivan KA; Mann SC; Gallop R
J Clin Psychiatry; 2001 Oct; 62(10):772-5. PubMed ID: 11816865
[TBL] [Abstract][Full Text] [Related]
3. Treatment of tardive dyskinesia with donepezil.
Caroff SN; Campbell EC; Havey JC; Sullivan KA; Katz IR; Mann SC
J Clin Psychiatry; 2001 Feb; 62(2):128-9. PubMed ID: 11247101
[No Abstract] [Full Text] [Related]
4. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
5. Effect of donepezil added to atypical antipsychotics on cognition in patients with schizophrenia: an open-label trial.
Chung YC; Lee CR; Park TW; Yang KH; Kim KW
World J Biol Psychiatry; 2009; 10(2):156-62. PubMed ID: 19514097
[TBL] [Abstract][Full Text] [Related]
6. Effect of donepezil on tardive dyskinesia.
Ogunmefun A; Hasnain M; Alam A; Osuala T; Regenold WT
J Clin Psychopharmacol; 2009 Feb; 29(1):102-4. PubMed ID: 19142126
[No Abstract] [Full Text] [Related]
7. Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.
Mazeh D; Zemishlani H; Barak Y; Mirecki I; Paleacu D
Int Psychogeriatr; 2006 Sep; 18(3):429-36. PubMed ID: 16478570
[TBL] [Abstract][Full Text] [Related]
8. Treatment of tardive dyskinesia with galantamine: a randomized controlled crossover trial.
Caroff SN; Walker P; Campbell C; Lorry A; Petro C; Lynch K; Gallop R
J Clin Psychiatry; 2007 Mar; 68(3):410-5. PubMed ID: 17388711
[TBL] [Abstract][Full Text] [Related]
9. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia.
Stryjer R; Strous RD; Bar F; Werber E; Shaked G; Buhiri Y; Kotler M; Weizman A; Rabey JM
Clin Neuropharmacol; 2003; 26(1):12-7. PubMed ID: 12567159
[TBL] [Abstract][Full Text] [Related]
11. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
Barnes TR; McPhillips MA
Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
[TBL] [Abstract][Full Text] [Related]
12. Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study.
Stryjer R; Strous R; Bar F; Shaked G; Shiloh R; Rozencwaig S; Grupper D; Buchman N; Kotler M; Rabey JM; Weizman A
Hum Psychopharmacol; 2004 Jul; 19(5):343-6. PubMed ID: 15252826
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
Keefe RS; Malhotra AK; Meltzer HY; Kane JM; Buchanan RW; Murthy A; Sovel M; Li C; Goldman R
Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic drug-induced extrapyramidal syndromes and tardive dyskinesia.
Casey DE
Schizophr Res; 1991; 4(2):109-20. PubMed ID: 1674881
[TBL] [Abstract][Full Text] [Related]
15. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
Lerner V; Kaptsan A; Miodownik C; Kotler M
Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
[TBL] [Abstract][Full Text] [Related]
16. Is donepezil useful for improving cognitive dysfunction in bipolar disorder?
Kelly T
J Affect Disord; 2008 Apr; 107(1-3):237-40. PubMed ID: 17825922
[TBL] [Abstract][Full Text] [Related]
17. Use of the selective serotonin 3 receptor antagonist ondansetron in the treatment of neuroleptic-induced tardive dyskinesia.
Sirota P; Mosheva T; Shabtay H; Giladi N; Korczyn AD
Am J Psychiatry; 2000 Feb; 157(2):287-9. PubMed ID: 10671405
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of tardive dyskinesia after a nine month naturalistic randomized trial comparing olanzapine with conventional treatment for schizophrenia and related disorders.
de Jesus Mari J; Lima MS; Costa AN; Alexandrino N; Rodrigues-Filho S; de Oliveira IR; Tollefson GD
Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):356-61. PubMed ID: 15538607
[TBL] [Abstract][Full Text] [Related]
19. Negative symptoms, cognitive dysfunction, tardive akathisia and tardive dyskinesia.
Sachdev P; Hume F; Toohey P; Doutney C
Acta Psychiatr Scand; 1996 Jun; 93(6):451-9. PubMed ID: 8831862
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of low-dose donepezil in schizophrenia.
Erickson SK; Schwarzkopf SB; Palumbo D; Badgley-Fleeman J; Smirnow AM; Light GA
Clin Neuropharmacol; 2005; 28(4):179-84. PubMed ID: 16062097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
